Skip Navigation

Publicaciones covid-9

Resource Feedback

If you know about a problem with one of our resource records, we want to know about it!

Resource A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: safety, reactogenicity and immunogenicity
URL https://www.medrxiv.org/content/10.1101/2021.10.04.21264522v1
(if you would like a response)
Verification Code:
CAPTCHA Image
Reload Image